Jamjoom Pharma And Mubadala Bio’s Venture Healthcare Partner To Expand Patient Access To Ustekinumab In UAE
Jamjoom Pharma and Mubadala Bio’s venture healthcare unit have formed a strategic partnership to broaden patient access to ustekinumab within the United Arab Emirates.
The story
in brief.
What happened, who it affects, and why it landed on our intelligence desk — in plain English, sixty seconds or less.
Jamjoom Pharma and Mubadala Bio’s venture healthcare unit have formed a strategic partnership to broaden patient access to ustekinumab within the United Arab Emirates. Ustekinumab is a biologic medication primarily used for treating autoimmune conditions such as psoriasis and Crohn’s disease. This collaboration aims to enhance distribution networks and improve availability for patients requiring this specialised therapy. The agreement reflects a growing trend of local partnerships in the Gulf region, designed to strengthen healthcare infrastructure and ensure consistent supply of advanced pharmaceutical treatments. For industry observers, this move signals a commitment to integrating innovative biologics into the regional healthcare system through established commercial channels.
Indicative index of skill mentions in professional job postings for the field this story moves (2019 = 1)
What this means
for your career.
Every headline redistributes opportunity. Here is who this one rewards — and how to be on the right side of it.
This partnership signals a significant shift in the UAE pharmaceutical landscape, prioritising localised access to advanced biologics. For you, this means roles in healthcare logistics, regulatory affairs, and market access are gaining critical importance. Professionals with expertise in supply chain optimisation and stakeholder management will find increased demand. You should focus on understanding the regulatory frameworks governing biologic distribution in the GCC. Consider upskilling in healthcare management or strategic sourcing to navigate these complex partnerships effectively. Networking with local pharmaceutical distributors and staying informed about regional health policies will position you advantageously. Proactively seeking roles that bridge clinical needs with commercial strategy will make you indispensable in this evolving sector.
For this story, the fields that convert it into pay are Healthcare Management, Strategic Sourcing, Supply Chain and Business and Management — exactly the programmes matched below. The chart shows the indicative salary uplift certified professionals report in each of those fields; every one of them is a click away, from £79, finishing in as few as 20 days.
Indicative ranges from published continuing-education salary studies, by field — each field is a recommended course below
Enrol in these
to benefit.
These programmes position you for exactly this shift — online, self-paced, and finishing with a verifiable certificate you can share the day you pass.
Best match
Certificate in Healthcare Management
Recommended
Certificate in Strategic Sourcing
Recommended
Certificate in Supply Chain
Recommended
Certificate in Business and Management
Launch pricing shown against standard certificate value. The fee you see today is the fee you lock in.
This briefing is based on reporting by TradingView on 22 Oct, 09:46. Read the original coverage →
Read the news. Then outrun it.
Every LSBR programme is online, self-paced and from £79 — so a headline today can be your credential this month.